Limitless Bladder Bioregulator (Chitomur)



Amount Per Capsule

Chitomur® bioregulator complex A-12 (bovine bladder amino acid) – 10mg*

*Daily Value not established

Other ingredients:

Microcrystalline Cellulose, Gelatin and Calcium Stearate

Chitomur® Bladder Peptide Bioregulator

Chitomur is a bioregulator containing natural bladder peptides. It has been studied to restore proper bladder function by reducing peptide deficiency and promoting protein synthesis within bladder cells.

Chitomur presents an opportunity to research peptide-based approaches for bladder-related conditions, particularly in aging populations. Its natural composition and potential benefits make it an intriguing subject for further investigation.

Potential Research Applications

Chitomur shows promise in several therapeutic areas. Its potential benefits span various urinary and bladder conditions, particularly in older adults.

Urinary incontinence is a widespread issue that significantly impacts one’s quality of life. This condition affects a diverse range of individuals, transcending age and gender boundaries.

For men over 40, prostate-related problems are often the culprit behind poor bladder control. Meanwhile, women who have undergone childbirth face an increased risk of developing urinary incontinence due to the physical strain on the pelvic floor muscles.

Beyond these common scenarios, various medical conditions can also disrupt the normal functioning of the bladder, leading to incontinence. Regardless of the underlying cause, this condition can be a source of embarrassment and discomfort, hindering daily activities and social interactions.

Overactive Bladder (OAB): Chitomur has been studied for its effects on overactive bladder, a condition common in elderly individuals. Research indicates that it can reduce the frequency of urgent urination and episodes of incontinence, improving the quality of life for patients.

Benign Prostatic Hyperplasia (BPH): In men with benign prostatic hyperplasia, Chitomur has shown potential in improving urination parameters and reducing symptoms associated with lower urinary tract dysfunction. This improvement persists even after the treatment period ends.

Chronic Cystitis: Chitomur may also be beneficial for chronic cystitis, a persistent inflammation of the bladder. Its tissue-specific action helps regulate metabolism in bladder wall cells, potentially alleviating symptoms and improving bladder function.

Menopausal Urinary Disorders: For women experiencing urinary disorders due to menopause, Chitomur has demonstrated a decrease in urgent micturition urges and incontinence episodes. This suggests it could be a potential treatment option for managing menopausal bladder issues.

Neurogenic Bladder Dysfunction: Chitomur’s ability to regulate bladder function and metabolism makes it a candidate for treating neurogenic bladder dysfunction, where nerve damage affects bladder control.

Therapeutic Areas of Interest

  • Chronic cystitis
  • Urinary incontinence
  • Pelvic organ prolapse
  • Prostate diseases
  • Climacteric syndrome
  • Neurogenic bladder dysfunction
  • Overactive bladder (OAB)
  • Benign prostatic hyperplasia (BPH)

Studies of Interest

  1. Gomberg VG, Ryzhak VG, Liutov RV. [Peptide geroprotector application for treatment of elderly and senile patients with prostatic hyperplasia]. Adv Gerontol. 2013;26(3):476-80. Russian. PMID: 24640697.
  2. Gomberg VG, Ryzhak AP, Lyutov RV. [Correction of age related bladder function decrease with peptide geroprotector in women]. Adv Gerontol. 2013;26(2):309-314. Russian. PMID: 28976156.

Similar Products

Scroll to Top